Table 2.
Laboratory Results at Baseline (N = 36).
| First stage | Second stage | Paired t-test | |
|---|---|---|---|
| Body mass index, kg/m2 | 24.4 ± 34.4 | 24.6 ± 34.6 | 0.796 |
| Total cholesterol, mg/dL | 157.3 ± 41.6 | 148.7 ± 28.0 | 0.308 |
| LDL, mg/dL | 79.7 ± 30.9 | 82.0 ± 25.1 | 0.729 |
| HDL, mg/dL | 53.6 ± 13.4 | 57.6 ± 16.5 | 0.263 |
| sd-LDL, mg/dL | 35.1 ± 12.9 | 29.6 13.9 ± | 0.088 |
| RLP-cho, mg/dL | 6.17 ± 4.12 | 3.45 ± 2.42 | 0.002 |
| Lp (a), mg/dL | 17.2 ± 21.3 | 17.4 ± 16.7 | 0.966 |
| DGLA, μg/dL | 42.1 ± 11.1 | 33.7 ± 13.6 | 0.008 |
| AA, μg/dL | 200.2 ± 44.1 | 172.4 ± 50.5 | 0.020 |
| EPA, μg/dL | 62.2 ± 40.3 | 83.2 ± 65.2 | 0.120 |
| DHA, μg/dL | 125.9 ± 40.1 | 115.4 ± 34.0 | 0.257 |
| EPA:AA ratio | 0.32 ± 0.20 | 0.50 ± 0.41 | 0.026 |
| DHA:AA ratio | 0.65 ± 0.20 | 0.70 ± 0.30 | 0.398 |
| High sensitivity CRP, mg/dL | 0.11 ± 0.10 | 0.10 ± 0.92 | 0.725 |
| CPK, U/L | 149.3 ± 186.1 | 186.1 ± 268.6 | 0.458 |
| BUN, mg/dL | 20.7 ± 7.8 | 22.2 ± 8.1 | 0.445 |
| Serum creatinine, mg/dL | 1.05 ± 0.28 | 1.10 ± 0.34 | 0.459 |
| eGFR, mL/min/1.73m2 | 53.3 ± 14.0 | 51.6 ± 16.0 | 0.630 |
| Cystatin C, mg/dL | 1.23 ± 1.69 | 1.69 ± 2.05 | 0.220 |
| Urine albumin, mg/g•Cre | 101.9 ± 77.0 | 77.0 ± 184.5 | 0.738 |
| HbA1c (%) | 5.66 ± 0.72 | 5.67 ± 0.73 | 0.961 |
| AST, U/L | 25.7 ± 7.7 | 25.1 ± 8.0 | 0.743 |
| ALT, U/L | 22.8 ± 18.2 | 18.2 ± 9.0 | 0.100 |
| Platelet count, ×104μL | 19.7 ± 5.4 | 23.8 ± 16.2 | 0.147 |
| Fib-4 index | 2.25 ± 1.10 | 2.28 ± 1.14 | 0.897 |
AA: arachidonic acid; ALT: alanine aminotransferase; AST: aspartate aminotransferase; BUN: blood urea nitrogen; CPK: creatine phosphokinase; CRP: C-reactive protein; DHA: docosahexaenoic acid; DHLA: dihydro gamma-linolenic acid; eGFR: estimated glomerular filtration rate; EPA: eicosapentaenoic acid; Fib-4: fibrosis-4; HbA1c: hemoglobin A1c; HDL: high density lipoprotein; LDL: low density lipoprotein; Lp: lipoprotein; RLP-cho: remnant like particles-cholesterol; sd-LDL: small dense low density lipoprotein.